ESTABLISING THE ROLE OF THE BRAIN METASTASES SPECIALIST NURSE IN A LARGE REGIONAL UNIT: REVIEW OF A 2 YEAR JOURNEY

Abstract AIMS In 2022, the Oxford University Foundation Trust recognized the unique journey of patients with brain metas- tases especially those requiring surgery, distinct from those with primary brain tumors. This led to the employ- ment of a Surgical Brain Metastases Nurse. With an estimated 20-40% of advanced-stage cancers metastasizing to the brain, brain metastases are more common than primary tumors and a significant contributor to can- cer mortality. The role of the nurse was designed to streamline the patient pathway, provide individualized support, liaise closely with local referrers, reduce time to MDT, and prevent repeated MDT discussions. METHODS Establishing this role involved identifying key contacts across the referring hospital network, including neu- rosurgeons, oncologists, specialized neuroradiologists, radiotherapists, neuropsychologists, physiotherapists, occupational therapists, acute oncology nurses, and palliative care teams. The goal was to streamline the brain metastasis patient pathway. RESULTS Data will be presented on the number of cases reviewed pre-MDT, time from referral to MDT, time to treatment if indicated, and survivorship. Additionally, examples of inappropriate referrals and education provided to primary cancer physicians will be included. Patient feedback and clinical expertise will highlight the nurse specialist’s influence. CONCLUSION The introduction of this role has significantly reduced MDT time and provided comprehensive information for MDT neuro discussions. It has promoted continuity of patient care and transition of care with a single focal CNS point of contact for brain metastasis. Timely coordination across the patient pathway has led to patient satisfaction and improved outcomes.